SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001193125-15-087567
Filing Date
2015-03-11
Accepted
2015-03-11 17:06:00
Documents
13

Document Format Files

Seq Description Document Type Size
1 F-1 d886982df1.htm F-1 2812869
2 EX-23.1 d886982dex231.htm EX-23.1 2046
3 EX-23.2 d886982dex232.htm EX-23.2 2063
4 GRAPHIC g886982g12x04.jpg GRAPHIC 51679
5 GRAPHIC g886982g30h23.jpg GRAPHIC 80013
6 GRAPHIC g886982g33l91.jpg GRAPHIC 153145
7 GRAPHIC g886982g34y62.jpg GRAPHIC 76580
8 GRAPHIC g886982g45f49.jpg GRAPHIC 104904
9 GRAPHIC g886982g46k09.jpg GRAPHIC 228201
10 GRAPHIC g886982g52h97.jpg GRAPHIC 74022
11 GRAPHIC g886982g64w73.jpg GRAPHIC 84379
12 GRAPHIC g886982g78v39.jpg GRAPHIC 72137
13 GRAPHIC g886982g99e27.jpg GRAPHIC 54565
  Complete submission text file 0001193125-15-087567.txt   4169120
Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9
Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: F-1 | Act: 33 | File No.: 333-202665 | Film No.: 15693481
SIC: 2834 Pharmaceutical Preparations